87 related articles for article (PubMed ID: 20965718)
1. Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
Campa D; Hüsing A; Chang-Claude J; Dostal L; Boeing H; Kröger J; Tjønneland A; Roswall N; Overvad K; Dahm CC; Rodríguez L; Sala N; Pérez MJ; Larrañaga N; Chirlaque MD; Ardanaz E; Khaw KT; Wareham N; Allen NE; Travis RC; Trichopoulou A; Naska A; Bamia C; Palli D; Sieri S; Tumino R; Sacerdote C; van Kranen HJ; Bas Bueno-de-Mesquita H; Stattin P; Johansson M; Chajes V; Rinaldi S; Romieu I; Siddiq A; Norat T; Riboli E; Kaaks R; Canzian F
Eur J Cancer; 2011 Feb; 47(3):420-7. PubMed ID: 20965718
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
Canzian F; Cox DG; Setiawan VW; Stram DO; Ziegler RG; Dossus L; Beckmann L; Blanché H; Barricarte A; Berg CD; Bingham S; Buring J; Buys SS; Calle EE; Chanock SJ; Clavel-Chapelon F; DeLancey JO; Diver WR; Dorronsoro M; Haiman CA; Hallmans G; Hankinson SE; Hunter DJ; Hüsing A; Isaacs C; Khaw KT; Kolonel LN; Kraft P; Le Marchand L; Lund E; Overvad K; Panico S; Peeters PH; Pollak M; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Yeager M; Hoover RN; Riboli E; Thomas G; Henderson BE; Kaaks R; Feigelson HS
Hum Mol Genet; 2010 Oct; 19(19):3873-84. PubMed ID: 20634197
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
Campa D; Hüsing A; Stein A; Dostal L; Boeing H; Pischon T; Tjønneland A; Roswall N; Overvad K; Østergaard JN; Rodríguez L; Sala N; Sánchez MJ; Larrañaga N; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Allen NE; Lagiou P; Trichopoulou A; Trichopoulos D; Palli D; Sieri S; Tumino R; Sacerdote C; van Kranen H; Bueno-de-Mesquita HB; Hallmans G; Johansson M; Romieu I; Jenab M; Cox DG; Siddiq A; Riboli E; Canzian F; Kaaks R
PLoS One; 2011 Feb; 6(2):e16914. PubMed ID: 21373201
[TBL] [Abstract][Full Text] [Related]
4. Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC).
Campa D; Claus R; Dostal L; Stein A; Chang-Claude J; Meidtner K; Boeing H; Olsen A; Tjønneland A; Overvad K; Rodríguez L; Bonet C; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Allen NE; Trichopoulou A; Bamia C; Benetou V; Palli D; Agnoli C; Panico S; Tumino R; Sacerdote C; van Kranen H; Bas Bueno-de-Mesquita H; Peeters PH; van Gils CH; Lenner P; Sund M; Lund E; Gram IT; Rinaldi S; Chajes V; Romieu I; Engel P; Boutron-Ruault MC; Clavel-Chapelon F; Siddiq A; Riboli E; Canzian F; Kaaks R
Breast Cancer Res Treat; 2011 Jun; 127(3):761-7. PubMed ID: 21116708
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival.
Nguyen PL; Ma J; Chavarro JE; Freedman ML; Lis R; Fedele G; Fiore C; Qiu W; Fiorentino M; Finn S; Penney KL; Eisenstein A; Schumacher FR; Mucci LA; Stampfer MJ; Giovannucci E; Loda M
J Clin Oncol; 2010 Sep; 28(25):3958-64. PubMed ID: 20679621
[TBL] [Abstract][Full Text] [Related]
6. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
7. Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer.
Beuten J; Gelfond JA; Franke JL; Weldon KS; Crandall AC; Johnson-Pais TL; Thompson IM; Leach RJ
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1869-80. PubMed ID: 19505920
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk.
Campa D; McKay J; Sinilnikova O; Hüsing A; Vogel U; Hansen RD; Overvad K; Witt PM; Clavel-Chapelon F; Boutron-Ruault MC; Chajes V; Rohrmann S; Chang-Claude J; Boeing H; Fisher E; Trichopoulou A; Trichopoulos D; Palli D; Villarini A; Sacerdote C; Mattiello A; Tumino R; Peeters PH; van Gils CH; Bas Bueno-de-Mesquita H; Lund E; Chirlaque MD; Sala N; Suarez LR; Barricarte A; Dorronsoro M; Sánchez MJ; Lenner P; Hallmans G; Tsilidis K; Bingham S; Khaw KT; Gallo V; Norat T; Riboli E; Rinaldi S; Lenoir G; Tavtigian SV; Canzian F; Kaaks R
Breast Cancer Res Treat; 2009 Dec; 118(3):565-74. PubMed ID: 19252981
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindström S; Albanes D; Ziegler RG; McCullough ML; Siddiq A; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock SJ; Crawford ED; Diver WR; Gapstur SM; Giovannucci E; Gu F; Haiman CA; Hayes RB; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Kraft P; Le Marchand L; Overvad K; Polidoro S; Riboli E; Schumacher FR; Stevens VL; Trichopoulos D; Virtamo J; Willett WC; Key TJ
Int J Cancer; 2013 Jul; 133(2):495-504. PubMed ID: 23341348
[TBL] [Abstract][Full Text] [Related]
10. MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study.
Loh YH; Mitrou PN; Bowman R; Wood A; Jeffery H; Luben RN; Lentjes MA; Khaw KT; Rodwell SA
DNA Repair (Amst); 2010 Apr; 9(4):421-8. PubMed ID: 20096652
[TBL] [Abstract][Full Text] [Related]
11. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
Travis RC; Schumacher F; Hirschhorn JN; Kraft P; Allen NE; Albanes D; Berglund G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Calle EE; Chanock S; Dunning AM; Hayes R; Feigelson HS; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Kaaks R; Kolonel LN; Ma J; Rodriguez L; Riboli E; Stampfer M; Stram DO; Thun MJ; Tjønneland A; Trichopoulos D; Vineis P; Virtamo J; Le Marchand L; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2734-44. PubMed ID: 19789370
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.
Holick CN; Stanford JL; Kwon EM; Ostrander EA; Nejentsev S; Peters U
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1990-9. PubMed ID: 17932346
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.
Johansson M; McKay JD; Stattin P; Canzian F; Boillot C; Wiklund F; Adami HO; Bälter K; Grönberg H; Kaaks R
Int J Cancer; 2007 Feb; 120(3):539-42. PubMed ID: 17096324
[TBL] [Abstract][Full Text] [Related]
14. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Setiawan VW; Schumacher FR; Haiman CA; Stram DO; Albanes D; Altshuler D; Berglund G; Buring J; Calle EE; Clavel-Chapelon F; Cox DG; Gaziano JM; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn J; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Ma J; Le Marchand L; Linseisen J; Lund E; Navarro C; Overvad K; Palli D; Peeters PH; Pike MC; Riboli E; Stampfer MJ; Thun MJ; Travis R; Trichopoulos D; Yeager M; Ziegler RG; Spencer Feigelson H; Chanock SJ
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2237-46. PubMed ID: 18006912
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic variants in autophagy-lysosome pathway genes with susceptibility and survival to prostate cancer.
Zhu Q; Meng Y; Li S; Xin J; Du M; Wang M; Cheng G
Gene; 2022 Jan; 808():145953. PubMed ID: 34500048
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk.
Barry KH; Koutros S; Andreotti G; Sandler DP; Burdette LA; Yeager M; Beane Freeman LE; Lubin JH; Ma X; Zheng T; Alavanja MC; Berndt SI
Carcinogenesis; 2012 Feb; 33(2):331-7. PubMed ID: 22102698
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
Stevens VL; Rodriguez C; Talbot JT; Pavluck AL; Thun MJ; Calle EE
Prostate; 2008 Sep; 68(12):1336-40. PubMed ID: 18500687
[TBL] [Abstract][Full Text] [Related]
18. MSMB gene variant alters the association between prostate cancer and number of sexual partners.
Stott-Miller M; Wright JL; Stanford JL
Prostate; 2013 Dec; 73(16):1803-9. PubMed ID: 24037734
[TBL] [Abstract][Full Text] [Related]
19. Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.
Campa D; Hüsing A; Dostal L; Stein A; Drogan D; Boeing H; Tjønneland A; Roswall N; Østergaard JN; Overvad K; Rodríguez L; Bonet C; Sánchez MJ; Larrañaga N; Huerta JM; Ardanaz E; Khaw KT; Wareham N; Travis RC; Allen NE; Trichopoulou A; Zylis D; Karapetyan T; Palli D; Sieri S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Lenner P; Johansson M; Jenab M; Cox D; Siddiq A; Kaaks R; Canzian F
Oncol Rep; 2011 Oct; 26(4):979-86. PubMed ID: 21725602
[TBL] [Abstract][Full Text] [Related]
20. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
